Value-Based Generic Drug Evaluation Focus on Chinese Real-World Evidence

doi:10.34172/ijhpm.2023.7970

. 2023:12:7970.

doi: 10.34172/ijhpm.2023.7970. Epub 2023 Sep 10.

Value-Based Generic Drug Evaluation Focus on Chinese Real-World Evidence

Jinmiao Lu¹, Xiaohua Ying², Zhiping Li¹

Affiliations

¹ Department of Clinical Pharmacy, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China.
² NHC Key Laboratory of Health Technology Assessment, Department of Health Economics, School of Public Health, Fudan University, Shanghai, China.

PMID: 38618799
PMCID: PMC10590237
DOI: 10.34172/ijhpm.2023.7970

Value-Based Generic Drug Evaluation Focus on Chinese Real-World Evidence

Jinmiao Lu et al. Int J Health Policy Manag. 2023.

. 2023:12:7970.

doi: 10.34172/ijhpm.2023.7970. Epub 2023 Sep 10.

Authors

Jinmiao Lu¹, Xiaohua Ying², Zhiping Li¹

Affiliations

¹ Department of Clinical Pharmacy, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China.
² NHC Key Laboratory of Health Technology Assessment, Department of Health Economics, School of Public Health, Fudan University, Shanghai, China.

PMID: 38618799
PMCID: PMC10590237
DOI: 10.34172/ijhpm.2023.7970

No abstract available

PubMed Disclaimer

Conflict of interest statement

Authors declare that they have no competing interests.

Figures

See this image and copyright information in PMC

Cited by

Multi-dimensional Perspective Pharmaceutical Evaluation: A Path to Enhancing Healthcare Decision-Making in Real-World.
Lu J, Ying X, Li Z. Lu J, et al. Int J Health Policy Manag. 2024;13:8295. doi: 10.34172/ijhpm.2024.8295. Epub 2024 Mar 5. Int J Health Policy Manag. 2024. PMID: 39099520 Free PMC article. No abstract available.

References

1. Aronson JK, Green AR. Me-too pharmaceutical products: history, definitions, examples, and relevance to drug shortages and essential medicines lists. Br J Clin Pharmacol. 2020;86(11):2114–2122. doi: 10.1111/bcp.14327. - DOI - PMC - PubMed
1. Hemel DJ, Ouellette LL. The generic drug trilemma. In: Entrepreneurship and Innovation Policy and the Economy. National Bureau of Economic Research; 2022.
1. NHC. Notice of Comprehensive Clinical Evaluation of Drugs. 2021. http://www.nhc.gov.cn/yaozs/s2908/202107/532e20800a47415d84adf3797b0f486....
1. Albarqouni L, Palagama S, Chai J, et al. Overuse of medications in low- and middle-income countries: a scoping review. Bull World Health Organ. 2023;101(1):36–61D. doi: 10.2471/blt.22.288293. - DOI - PMC - PubMed
1. Mühlbacher AC, Kaczynski A. Making good decisions in healthcare with multi-criteria decision analysis: the use, current research and future development of MCDA. Appl Health Econ Health Policy. 2016;14(1):29–40. doi: 10.1007/s40258-015-0203-4. - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central

[1] Aronson JK, Green AR. Me-too pharmaceutical products: history, definitions, examples, and relevance to drug shortages and essential medicines lists. Br J Clin Pharmacol. 2020;86(11):2114–2122. doi: 10.1111/bcp.14327. - DOI - PMC - PubMed

[2] Aronson JK, Green AR. Me-too pharmaceutical products: history, definitions, examples, and relevance to drug shortages and essential medicines lists. Br J Clin Pharmacol. 2020;86(11):2114–2122. doi: 10.1111/bcp.14327. - DOI - PMC - PubMed

[3] Hemel DJ, Ouellette LL. The generic drug trilemma. In: Entrepreneurship and Innovation Policy and the Economy. National Bureau of Economic Research; 2022.

[4] Hemel DJ, Ouellette LL. The generic drug trilemma. In: Entrepreneurship and Innovation Policy and the Economy. National Bureau of Economic Research; 2022.

[5] NHC. Notice of Comprehensive Clinical Evaluation of Drugs. 2021. http://www.nhc.gov.cn/yaozs/s2908/202107/532e20800a47415d84adf3797b0f486....

[6] NHC. Notice of Comprehensive Clinical Evaluation of Drugs. 2021. http://www.nhc.gov.cn/yaozs/s2908/202107/532e20800a47415d84adf3797b0f486....

[7] Albarqouni L, Palagama S, Chai J, et al. Overuse of medications in low- and middle-income countries: a scoping review. Bull World Health Organ. 2023;101(1):36–61D. doi: 10.2471/blt.22.288293. - DOI - PMC - PubMed

[8] Albarqouni L, Palagama S, Chai J, et al. Overuse of medications in low- and middle-income countries: a scoping review. Bull World Health Organ. 2023;101(1):36–61D. doi: 10.2471/blt.22.288293. - DOI - PMC - PubMed

[9] Mühlbacher AC, Kaczynski A. Making good decisions in healthcare with multi-criteria decision analysis: the use, current research and future development of MCDA. Appl Health Econ Health Policy. 2016;14(1):29–40. doi: 10.1007/s40258-015-0203-4. - DOI - PubMed

[10] Mühlbacher AC, Kaczynski A. Making good decisions in healthcare with multi-criteria decision analysis: the use, current research and future development of MCDA. Appl Health Econ Health Policy. 2016;14(1):29–40. doi: 10.1007/s40258-015-0203-4. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Value-Based Generic Drug Evaluation Focus on Chinese Real-World Evidence

Affiliations

Value-Based Generic Drug Evaluation Focus on Chinese Real-World Evidence

Authors

Affiliations

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources